No Sanctions For Eli Lilly In Teva Migraine Drug Patent Row
Eli Lilly won't be sanctioned in a battle with Teva Pharmaceuticals over patents tied to a migraine biologic, a Massachusetts federal judge ruled in an order made public Tuesday, saying Eli...To view the full article, register now.
Already a subscriber? Click here to view full article